PROCTER & GAMBLE HEALTH
Back to Income Statement
|
PROCTER & GAMBLE HEALTH Last 5 Year Revenue History
[Standalone]
Jun2024 | Jun2023 | Jun2022 | Jun2021 | Jun2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,151 Cr | ₹1,230 Cr | ₹1,114 Cr | ₹1,009 Cr | ₹1,356 Cr |
What is the latest Revenue of PROCTER & GAMBLE HEALTH ?
Year | Revenue |
---|---|
Jun2024 | ₹1,151 Cr |
Jun2023 | ₹1,230 Cr |
Jun2022 | ₹1,114 Cr |
Jun2021 | ₹1,009 Cr |
Jun2020 | ₹1,356 Cr |
How is Revenue of PROCTER & GAMBLE HEALTH Trending?
Years | Revenue | % Change | |
---|---|---|---|
Jun2024 | ₹1,151 Cr | -6.37 | |
Jun2023 | ₹1,230 Cr | 10.34 | |
Jun2022 | ₹1,114 Cr | 10.48 | |
Jun2021 | ₹1,009 Cr | -25.60 | |
Jun2020 | ₹1,356 Cr | - |
Compare Revenue of peers of PROCTER & GAMBLE HEALTH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PROCTER & GAMBLE HEALTH | ₹9,730.8 Cr | 0% | -1.1% | 14.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,620.0 Cr | -1.3% | 1% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,509.0 Cr | -3.2% | -0.3% | 48% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,571.0 Cr | 1.2% | 10.7% | 19.5% | Stock Analytics | |
CIPLA | ₹118,336.0 Cr | -0.6% | -2.2% | -0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,522.0 Cr | -1.5% | -5.9% | -5.1% | Stock Analytics |
PROCTER & GAMBLE HEALTH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PROCTER & GAMBLE HEALTH | 0% |
-1.1% |
14.9% |
SENSEX | -0.5% |
-0.3% |
1% |
You may also like the below Video Courses